RPTX MT Newswires 15 hours ago Update: Gilead Sciences to Acquire Repare Therapeutics' Investigational Cancer Treatment; Repare Shares Rise âž– AI Sentiment Neutral 5/10
RPTX MT Newswires 16 hours ago Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday âž– AI Sentiment Neutral 5/10
RPTX MT Newswires 17 hours ago Gilead Sciences to Acquire Repare Therapeutics' Investigational Cancer Treatment 📈 AI Sentiment Highly Positive 8/10
RPTX Business Wire 18 hours ago Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration 📈 AI Sentiment Highly Positive 9/10